These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 32605658)

  • 81. Gain-of-function mutant p53 in cancer progression and therapy.
    Zhang C; Liu J; Xu D; Zhang T; Hu W; Feng Z
    J Mol Cell Biol; 2020 Sep; 12(9):674-687. PubMed ID: 32722796
    [TBL] [Abstract][Full Text] [Related]  

  • 82. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
    Beinse G; Just PA; Rance B; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Pasmant E; Batteux F; Borghese B; Alexandre J; Leroy K
    PLoS One; 2019; 14(3):e0214416. PubMed ID: 30908539
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Curcumin alleviates arsenic-induced toxicity in PC12 cells via modulating autophagy/apoptosis.
    Rahaman MS; Banik S; Akter M; Rahman MM; Sikder MT; Hosokawa T; Saito T; Kurasaki M
    Ecotoxicol Environ Saf; 2020 Sep; 200():110756. PubMed ID: 32464442
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
    Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
    Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
    [TBL] [Abstract][Full Text] [Related]  

  • 86. iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding.
    Ge W; Zhao K; Wang X; Li H; Yu M; He M; Xue X; Zhu Y; Zhang C; Cheng Y; Jiang S; Hu Y
    Cancer Cell; 2017 Nov; 32(5):561-573.e6. PubMed ID: 29033244
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.
    Tsvetkov P; Asher G; Reiss V; Shaul Y; Sachs L; Lotem J
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5535-40. PubMed ID: 15809436
    [TBL] [Abstract][Full Text] [Related]  

  • 88. P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy.
    Ma F; Wu J; Jiang Z; Huang W; Jia Y; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1272-1281. PubMed ID: 30959066
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin.
    Shen G; Xu C; Hu R; Jain MR; Gopalkrishnan A; Nair S; Huang MT; Chan JY; Kong AN
    Mol Cancer Ther; 2006 Jan; 5(1):39-51. PubMed ID: 16432161
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.
    Weinmann L; Wischhusen J; Demma MJ; Naumann U; Roth P; Dasmahapatra B; Weller M
    Cell Death Differ; 2008 Apr; 15(4):718-29. PubMed ID: 18202704
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Curcumin revitalizes Amyloid beta (25-35)-induced and organophosphate pesticides pestered neurotoxicity in SH-SY5Y and IMR-32 cells via activation of APE1 and Nrf2.
    Sarkar B; Dhiman M; Mittal S; Mantha AK
    Metab Brain Dis; 2017 Dec; 32(6):2045-2061. PubMed ID: 28861684
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 93. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.
    Shin D; Kim EH; Lee J; Roh JL
    Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Curcumin Derivative Epigenetically Reactivates Nrf2 Antioxidative Stress Signaling in Mouse Prostate Cancer TRAMP C1 Cells.
    Li W; Su ZY; Guo Y; Zhang C; Wu R; Gao L; Zheng X; Du ZY; Zhang K; Kong AN
    Chem Res Toxicol; 2018 Feb; 31(2):88-96. PubMed ID: 29228771
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001.
    Ning S; Sekar TV; Scicinski J; Oronsky B; Peehl DM; Knox SJ; Paulmurugan R
    Oncotarget; 2015 Aug; 6(25):21547-56. PubMed ID: 26280276
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway.
    Chian S; Zhao Y; Xu M; Yu X; Ke X; Gao R; Yin L
    Anticancer Drugs; 2019 Sep; 30(8):838-845. PubMed ID: 31415285
    [TBL] [Abstract][Full Text] [Related]  

  • 97. C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis.
    Srivastava S; Mishra S; Surolia A; Panda D
    Biosci Rep; 2016; 36(2):. PubMed ID: 26980197
    [TBL] [Abstract][Full Text] [Related]  

  • 98. p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53.
    Romeo MA; Gilardini Montani MS; Benedetti R; Arena A; D'Orazi G; Cirone M
    Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33668399
    [No Abstract]   [Full Text] [Related]  

  • 99. Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells.
    Kang KA; Piao MJ; Hyun YJ; Zhen AX; Cho SJ; Ahn MJ; Yi JM; Hyun JW
    Exp Mol Med; 2019 Apr; 51(4):1-14. PubMed ID: 30988303
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines.
    Patiño-Morales CC; Soto-Reyes E; Arechaga-Ocampo E; Ortiz-Sánchez E; Antonio-Véjar V; Pedraza-Chaverri J; García-Carrancá A
    Redox Biol; 2020 Jan; 28():101320. PubMed ID: 31526948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.